Aurora Spine Corp (ASG) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.004x

Based on the latest financial reports, Aurora Spine Corp (ASG) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-12.85K ≈ $-9.29K USD) by net assets (CA$3.62 Million ≈ $2.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Aurora Spine Corp to measure how much of total assets are equity-financed.

Aurora Spine Corp - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Aurora Spine Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ASG cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Aurora Spine Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aurora Spine Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Kuk Young G&M Co. Ltd
KQ:006050
0.009x
Dataworks Group Ltd
AU:DWG
-0.337x
CNPLUS Co. Ltd.
KQ:115530
0.851x
Seker Finansal Kiralama AS
IS:SEKFK
0.184x
Cellectar Biosciences Inc
NASDAQ:CLRB
-0.438x
Ata Gayrimenkul Yatirim Ortakligi AS
IS:ATAGY
0.003x
Clean & Science co. Ltd
KQ:045520
0.147x
Fastator AB
ST:FASTAT
0.055x

Annual Cash Flow Conversion Efficiency for Aurora Spine Corp (2012–2025)

The table below shows the annual cash flow conversion efficiency of Aurora Spine Corp from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Aurora Spine Corp stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$3.81 Million
≈ $2.76 Million
CA$917.37K
≈ $663.61K
0.241x +0.01%
2024-12-31 CA$4.40 Million
≈ $3.18 Million
CA$1.06 Million
≈ $765.25K
0.241x +236.29%
2023-12-31 CA$5.30 Million
≈ $3.83 Million
CA$-935.06K
≈ $-676.41K
-0.177x +51.08%
2022-12-31 CA$4.32 Million
≈ $3.12 Million
CA$-1.56 Million
≈ $-1.13 Million
-0.361x +5.62%
2021-12-31 CA$5.57 Million
≈ $4.03 Million
CA$-2.13 Million
≈ $-1.54 Million
-0.382x -505.26%
2020-12-31 CA$3.28 Million
≈ $2.37 Million
CA$309.57K
≈ $223.94K
0.094x +22780.75%
2019-12-31 CA$1.77 Million
≈ $1.28 Million
CA$729.00
≈ $527.35
0.000x -99.72%
2018-12-31 CA$2.96 Million
≈ $2.14 Million
CA$435.79K
≈ $315.24K
0.147x +121.24%
2017-12-31 CA$1.65 Million
≈ $1.19 Million
CA$-1.15 Million
≈ $-828.63K
-0.694x -41.82%
2016-12-31 CA$3.47 Million
≈ $2.51 Million
CA$-1.70 Million
≈ $-1.23 Million
-0.489x +34.12%
2015-12-31 CA$4.69 Million
≈ $3.39 Million
CA$-3.48 Million
≈ $-2.52 Million
-0.742x +63.57%
2014-12-31 CA$3.50 Million
≈ $2.53 Million
CA$-7.13 Million
≈ $-5.16 Million
-2.038x +6.72%
2013-12-31 CA$1.44 Million
≈ $1.04 Million
CA$-3.15 Million
≈ $-2.28 Million
-2.184x +73.39%
2012-12-31 CA$158.51K
≈ $114.66K
CA$-1.30 Million
≈ $-941.41K
-8.210x --

About Aurora Spine Corp

V:ASG Canada Medical Devices
Market Cap
$11.30 Million
CA$15.62 Million CAD
Market Cap Rank
#26731 Global
#1089 in Canada
Share Price
CA$0.20
Change (1 day)
-4.76%
52-Week Range
CA$0.20 - CA$0.33
All Time High
CA$0.91
About

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar inter… Read more